Published in Zh Mikrobiol Epidemiol Immunobiol on January 27, 2006
[The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever]. Vopr Virusol (1994) 1.24
[Opportunistic microorganisms in urinary tract diseases]. Vestn Ross Akad Med Nauk (2001) 1.09
[The bacterial QS-systems and prospects of creation of new metabolic probiotic preparations]. Vestn Ross Akad Med Nauk (2006) 0.82
[Associated infections in acute bronchopulmonary infections in children]. Vestn Ross Akad Med Nauk (2003) 0.81
[Highly pathogenic avian influenza virus inducing influenza pneumonia in humans]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.81
[The pathomorphology and pathogenesis of glanders in laboratory animals]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.80
[Chemotherapy for Bolivian hemorrhagic fever in experimentally infected guinea pigs]. Vopr Virusol (2009) 0.79
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. Antibiot Khimioter (2008) 0.78
[Immunologic properties of the soluble antigen of the antigen of Rickettsia prowazekii. I. Antigenic structure of Rickettsia prowazekii based on chromatographic analysis on DEAE-cellulose]. Zh Mikrobiol Epidemiol Immunobiol (1965) 0.78
EPR study of some rare-earth ions (Dy3+, Tb3+, and Nd3+) in YBa2Cu3O6-compound. J Magn Reson (2003) 0.78
[Use of guinea pigs to evaluate the efficacy of a heterological immunoglobulin against Bolivian hemorrhagic fever]. Vopr Virusol (2009) 0.78
[Studies on immunological properties of a soluble antigen of Rickettsia prowazekii. II. Isolation with the aid of DEAE-cellulose of a soluble antigen of Rickettsia prowazekii and its immunological properties]. Zh Mikrobiol Epidemiol Immunobiol (1965) 0.78
[Tamsulosin administration for prophylaxis and treatment of stent-related symptoms]. Urologiia (2010) 0.78
[Development and study of properties of immunoglobulins against Lassa fever]. Vopr Virusol (1997) 0.78
[Effectiveness of virazol, realdiron and interferon inductors in experimental Omsk hemorrhagic fever]. Vopr Virusol (2003) 0.77
[Prospects of obtaining Salmonella cya and srp mutants to be used as vaccine strains]. Vestn Ross Akad Med Nauk (1995) 0.77
[Combined treatment including ozonotherapy of patients with viral hepatitis ]. Vopr Kurortol Fizioter Lech Fiz Kult (2008) 0.77
[Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections]. Antibiot Khimioter (2009) 0.77
[Seroimmunologic monitoring of microorganisms of Rickettsia and Bartonella species microorganisms in the Moscow region]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.77
[Isolation and identification of Crimean-Congo hemorrhagic fever virus in the Stavropol territory]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.77
[The laboratory diagnosis of an outbreak of hemorrhagic fever at Oblivskaya village, Rostov Province: proof of the etiological role of the Crimean-Congo hemorrhagic fever virus]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.77
[Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte]. Antibiot Khimioter (2000) 0.76
[Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients]. Vopr Virusol (2012) 0.76
[Use of the monkey pox virus for evaluating the intensity of the immunity against smallpox in experiments on M. rhesus]. Vopr Virusol (1978) 0.76
[Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Vopr Virusol (2004) 0.76
[Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)]. Antibiot Khimioter (2008) 0.76
[Aerosol vaccination against dangerous infectious diseases]. Vestn Ross Akad Med Nauk (1999) 0.76
[Design of equine serum-based Marburg virus immunoglobulin]. Vopr Virusol (2008) 0.76
[Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment]. Vopr Virusol (2006) 0.76
[Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.76
[Use of recombinant Salmonella strains for supplying the macro-organism with biologically active molecules]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.76
[The rate of HCV-RNA detection in the serum, saliva, and tissue of the minor salivary glands in chronic hepatitis C with Sjogren's syndrome]. Klin Med (Mosk) (2003) 0.75
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Antibiot Khimioter (2010) 0.75
[Current concepts of the mechanisms of initiation and regulation of macrophage functional activity]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Physicochemical biology and biotechnology problems of microbiology and immunology]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[New findings concerning oral immunization with live EB plague vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.75
[Molecular-biological aspects of producing vaccinal strains of influenza virus]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Principles for optimizing and guaging several processes in the technology of vaccine production. I. Several problems in guaging and optimizing thermal sterilization of fluids]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Experimental (preclinical) study of genetically engineered human interferon based on recombinant clones of E. coli 74 and Pseudomonas Sp VG-84]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Mechanisms of microorganism inactivation by phagocytes]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Technic of carrying out vaccinations with the needleless injector BIP-4]. Voen Med Zh (1970) 0.75
[Use of needleless injectors in smallpox immunization. 1. A macroand microscopic study of skin reaction to the administration of smallpox vaccine intradermally with needleless injectors]. Vopr Virusol (1969) 0.75
[Characteristics of nonspecific resistance in children with lung diseases due to opportunistic microflora]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Host proteins in purified concentrations of the influenza virus]. Vopr Virusol (1986) 0.75
[Effect of different factors on the permeability of mucous membranes for foreign substances and microorganisms (literature review)]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Clinical significance of leukocyte alteration in myocardial infarct]. Klin Med (Mosk) (1976) 0.75
[The effects of enzymes and secretions of the gastrointestinal tract on the EB vaccine strain]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Study of smallpox vaccine virus distribution in the body of rabbits following oral immunization]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Status and developmental prospects of the medical proton channel in the synchrocyclotron in Gatchina]. Med Radiol (Mosk) (1983) 0.75
[Penetration of vaccinia virus through the mucosa of the small intestine and its dissemination in the body following enteric immunization of monkeys]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Experience with use of immunomodulators in treatment of tonsillitis developed at the background of preimmunization by TEOVac]. Antibiot Khimioter (2011) 0.75
[Principles for construction of live oral vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Oral immunization with EV live plague vaccine in experiments on animals]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Experience using intravenous anesthesia in pediatric anesthesiology]. Klin Khir (1985) 0.75
[Analysis of several clinical, morphologic and biochemical responses to vaccination from the point of view of normal and pathologic conditions]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[The mechanism of immune alteration of leukocytes]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[The topicality of return to smallpox vaccination: problems and prospects]. Vestn Ross Akad Med Nauk (2006) 0.75
[Experience in performing vaccination against smallpox by the needleless method]. Voen Med Zh (1969) 0.75
[Hygienic substantiation of the comfort conditions for the microclimate of shipboard premises taking into account the acclimatization changes in sailors on a cruise]. Gig Sanit (1976) 0.75
[New findings concerning the mechanism of antibody synthesis at the cellular and molecular levels (review of the literature)]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Comparative assessment of the means and methods of immunizing humans against smallpox]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Morphologic changes in the skin and underlying tissues after the administration of biopreparations into the body by a needle-less (jet) method]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Current views on the side effects of vaccinations]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Achievements and prospects of biotechnology in the fields of microbiology and immunology]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Electron microscopic study of the kinetics of smallpox vaccine interaction with alveolar macrophages when administered intratracheally]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Morphology of the parietal peritoneum and peritoneal exudate in peritonitis]. Arkh Patol (1982) 0.75
[Current concepts of lymphocytic chalones as endogenous immunomodulators]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Enteral immunization with staphylococcal anatoxin of a limited group of people]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Mechanism of action of adjuvants]. Usp Sovrem Biol (1970) 0.75
[Use of antibiotics in the treatment of ulceronecrotic tonsillitis due to vaccination by tabletted smallpox vaccine]. Antibiot Khimioter (2010) 0.75
[Peculiarities of the reactions of a child's brain in closed cranio-cerebral injury]. Zh Nevropatol Psikhiatr Im S S Korsakova (1968) 0.75
[Programmed anesthesiologic assistance in a first-aid hospital]. Klin Khir (1986) 0.75
[Theoretical and practical aspects of the problem of peroral immunization at the present time]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.75
[A study of the immunobiological properties of the soluble antigen of Rickettsia prowazekii. IV. Stability of the antigen during storage]. Zh Mikrobiol Epidemiol Immunobiol (1967) 0.75
[Current ideas on some protective-adaptive mechanisms of the respiratory organ system in the light of aerosol (inhalation) immunization]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Adaptation of sailors to working conditions in the standardization of a microclimate of the living quarters on a ship]. Gig Tr Prof Zabol (1983) 0.75
[Developmental prospects in biotechnology and the legal possibilities in acknowledging as inventions achievements in this field]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Current problems of immunology in light of the immunoprophylaxis of infectious diseases]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[CO2 laser in the treatment of tumors of the bladder]. Sov Med (1985) 0.75
[New procedural methods of studying oral and parenteral forms of biopreparations in animal experiments]. Lab Delo (1970) 0.75
[Results of and prospects for the elaboration of mass vaccination methods]. Vestn Akad Med Nauk SSSR (1975) 0.75
[State of the sympathico-adrenal system in patients with pre-asthma conditions]. Vrach Delo (1976) 0.75
[Characteristics of the occurrence of infections of the skin and subcutaneous tissue in animal breeders and agricultural machine operators]. Vestn Dermatol Venerol (1983) 0.75
[Diagnostic value of local and segmentary-radicular leukocytosis in lumbosacral radiculitis in expert evaluation of disability]. Klin Med (Mosk) (1969) 0.75
[Genetic approaches to the development and study of vaccine strains of RNA viruses]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.75
[Study of allergic reactions in the body after experimental smallpox vaccination]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[On the fats of labeled tetanus anatoxins in the bodies of experimental animals. II]. Zh Mikrobiol Epidemiol Immunobiol (1968) 0.75
[Adaptability of patients to freely selected and forced physical exercise after myocardial infarction]. Kardiologiia (1991) 0.75
[Electron microscopic study of the kinetics of phagocytosis of the EB vaccine strain by pulmonary macrophages after the intratracheal immunization of guinea pigs]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.75
[Modern views on anaphylaxis as a form of the manifestation of body reactivity]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Chief trends and means of increasing the effectiveness of immunoprevention]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[The current status of Q fever immunoprophylaxis]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Etiology, genesis and systematics of postvaccinal reactions and complications]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[A study of the immunobiologic properties of soluble Rickettsia prowazekii antigen. VI. Sorbed preparations]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Principles of optimization and scaling of certain processes in the technology of vaccine production. IV. Typical problems of scaling certain processes in the technology of vaccine production]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.75